“Insulin lispro (Humalog) 7 units subcutaneous TID, 15 minutes before meal”.
The information behind Insulin lispro is that it was approved by the U.S. Food and Drug Administration (FDA) in 1996, becoming the first new insulin product to appear in the U.S. market in 14 years (Lilley, L. L., Savoca, D., & Lilley, L. L. 2011). It can be administered through a subcutaneous route, it has a 15 minutes onset. Its peak plasma concentration is 1 to 2 hours and its elimination half-life is usually 80 minutes, with 3 to 5 hours duration of action.
Insulin lispro (Humalog) is a rapid acting insulin, recommended to control diabetes in patients with type 1 and type 2 diabetes mellitus. When using insulins, the color, clarity, and appearance are important to understand for prevention of adverse effects, complications, and patient safety. A nurse should not use insulin lispro if patient blood sugar level is low, and patient has symptoms of hypoglycemia (low blood sugar). A nurse should not also inject insulin into a skin area that is thickened, red, swollen, or itchy. …show more content…
The subjective data and the order “insulin lispro (Humalog) 7 units subcutaneous TID, 15 minutes before meal”, indicates she is diabetic. Insulin lispro (Humalog) have the most rapid onset of action (roughly 15 minutes) as well as a shorter duration of action than other insulin categories. The effect of insulin lispro is like that of the endogenous insulin produced by the pancreas in response to a meal. During or after a meal, the glucose that is ingested stimulates the pancreas to secrete insulin. This insulin then facilitates the uptake of the excess glucose at hepatic insulin receptor sites for storage in the liver as glycogen (Lilley, L. L., Savoca, D., & Lilley, L. L.
The information behind Insulin lispro is that it was approved by the U.S. Food and Drug Administration (FDA) in 1996, becoming the first new insulin product to appear in the U.S. market in 14 years (Lilley, L. L., Savoca, D., & Lilley, L. L. 2011). It can be administered through a subcutaneous route, it has a 15 minutes onset. Its peak plasma concentration is 1 to 2 hours and its elimination half-life is usually 80 minutes, with 3 to 5 hours duration of action.
Insulin lispro (Humalog) is a rapid acting insulin, recommended to control diabetes in patients with type 1 and type 2 diabetes mellitus. When using insulins, the color, clarity, and appearance are important to understand for prevention of adverse effects, complications, and patient safety. A nurse should not use insulin lispro if patient blood sugar level is low, and patient has symptoms of hypoglycemia (low blood sugar). A nurse should not also inject insulin into a skin area that is thickened, red, swollen, or itchy. …show more content…
The subjective data and the order “insulin lispro (Humalog) 7 units subcutaneous TID, 15 minutes before meal”, indicates she is diabetic. Insulin lispro (Humalog) have the most rapid onset of action (roughly 15 minutes) as well as a shorter duration of action than other insulin categories. The effect of insulin lispro is like that of the endogenous insulin produced by the pancreas in response to a meal. During or after a meal, the glucose that is ingested stimulates the pancreas to secrete insulin. This insulin then facilitates the uptake of the excess glucose at hepatic insulin receptor sites for storage in the liver as glycogen (Lilley, L. L., Savoca, D., & Lilley, L. L.